Table 2.

Relationship between the EGFR mRNA expression and clinicopathologic features in ovarian cancer

	EGFR (+)		EGFR expression
Characteristics	n (%)	P	x ± s	P
Age, years
≥ 51	17/24 (70.8)	0.971	0.99 ± 0.24	0.123
< 51	19/27 (70.4)	0.971	0.83 ± 0.31	0.123
Histological type
Serous carcinoma	27/39 (69.2)	0.983	0.90 ± 0.32	0.885
Others	9/12 (75.0)	0.983	0.92 ± 0.18	0.885
Differentiation
Moderately/Well differentiated	7/11 (63.6)	0.587	0.86 ± 0.18	0.577
Poor differentiated	31/40 (77.5)	0.587	0.93 ± 0.33	0.577
Clinical stage
I-II	8/18 (44.4)	0.002	0.74 ± 0.29	0.003
III-IV	28/33 (84.8)	0.002	1.04 ± 0.20	0.003
Lymph node metastasis
No	22/32 (68.8)	0.708	0.89 ± 0.30	0.564
Yes	14/19 (73.7)	0.708	0.97 ± 0.22	0.564